In this guide
What is Evening Primrose Oil?
Evening primrose oil is a variable source of gamma-linolenic acid. Trial schedules are condition-specific and do not establish one routine dose. No U.S. DRI or established daily requirement exists for evening primrose oil or supplemental GLA. [1]
Typical Evening Primrose Oil Protocols
| Source and population | Form and amount each time | Frequency | Total exposure | Duration or boundary |
|---|---|---|---|---|
| Kumari 2024 · 126 premenopausal women with cyclical mastalgia | Evening primrose oil 1,000 mg per administration | Twice daily | 2,000 mg oil/day; GLA not reported in abstract | 6 months; factorial arms included vitamin E |
| Gholami 2025 · painful diabetic neuropathy | Evening primrose oil 1,000 mg per administration | Once daily or every 12 hours | 1,000 or 2,000 mg oil/day | 4 weeks; small three-group trial |
| Mastalgia synthesis 2021 | Various EPO products | Study-specific | No universal GLA dose | 13 trials; 1,752 randomized participants |
These rows reproduce sources. Do not average them into one universal regimen.
From source to outcome
Record both amounts.
No clear monotherapy edge.
Replication needed.
Which forms and label details matter?
Record oil mass and declared GLA separately. Different oils can supply different GLA per capsule; co-administered vitamin E changes the intervention.
How should it be stored?
Follow the label, close the container and protect it from heat, light and moisture.
Read the label before the claim
Match the studied preparation.
Keep the daily total visible.
A biomarker is not a clinical event.
What is it commonly used for?
Common claims include cyclical breast pain, neuropathic pain, eczema and menopausal symptoms. Results are mixed, often small and condition-specific.
What does human research show?
A 2021 review of 13 trials and 1,752 randomized participants found no meaningful advantage for evening primrose oil over placebo, topical NSAIDs, danazol or vitamin E for mastalgia. [2] Kumari later randomized 126 premenopausal women for six months; EPO 1,000 mg twice daily, vitamin E 400 mg once daily, and their combination improved pain, with the combination performing best. Because the intervention combined ingredients and the report has design/reporting limits, it does not overturn the broader monotherapy synthesis. [3] Gholami’s small 2025 neuropathy study compared 1,000 mg daily with 1,000 mg every 12 hours and mixed placebo schedules for four weeks; positive pain-score changes need replication and do not replace standard diabetes and neuropathy care. [4] NCCIH reports insufficient evidence for most promoted uses; oral EPO and borage oil do not meaningfully improve eczema in pooled evidence. [1]

How might it act?
Fatty acids enter membranes, serve as energy substrates or act as precursors to mediators according to their structure. This mechanism does not turn a blood-level change into prevention of a clinical event.
How does it compare with related products?
| Product | What the label needs to state | Practical distinction |
|---|---|---|
| Fish oil | EPA, DHA and total oil | Marine EPA+DHA mixture; findings from an EPA-only prescription drug do not automatically transfer. |
| Krill oil | EPA, DHA, phospholipids and shellfish source | Different source with a shellfish allergen; total oil mass does not reveal EPA+DHA mass. |
| Algal oil | DHA, any EPA and total oil | Non-fish source; formulations can be mainly DHA. |
| Cod liver oil | EPA, DHA, vitamin A and vitamin D | Adds fat-soluble vitamins that must be counted with other products. |
What are the risks and interactions?
GI upset and headache can occur. Review pregnancy, breastfeeding, bleeding risk, anticoagulants, antiplatelets, surgery and seizure history or medicines that lower seizure threshold. Do not substitute it for breast, neuropathy or skin evaluation.
Which medicines require review?
Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.
Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]
What should be monitored?
Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.
What happens when it is stopped?
No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.
Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.
What do public communities report?
Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.
Common questions about Evening Primrose Oil
Does evening primrose oil treat breast pain?
The pooled evidence found no clear advantage; one later combination trial does not establish EPO monotherapy.
Does it treat diabetic neuropathy?
A small four-week trial was positive, but confirmation and standard care remain necessary.
Does it treat eczema?
Pooled oral EPO and borage evidence does not show meaningful benefit.
Is 1,000 mg a GLA dose?
No. It usually refers to oil mass; read the declared GLA separately.
Can it be used in pregnancy?
Do not infer safety from retail availability; obtain obstetric review.
What should I track?
Oil and GLA per administration, frequency, co-ingredients, pain scale, adverse effects and review date.
Glossary
Terms for reading the evidence.
- ALA
- Essential 18-carbon omega-3; adult AIs refer to this form.
- EPA
- Long-chain omega-3; distinct from total oil weight.
- DHA
- Long-chain omega-3; often present in a different amount from EPA.
- Amount per administration
- Amount consumed at one time, distinct from daily total.
- Biomarqueur
- Biological measure that is not necessarily a clinical benefit.
- UL
- Tolerable Upper Intake Level established for a nutrient and defined scope.
How this guide was researched
Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.
Explore the sources
Sources preserve form, amount, frequency, population, duration and outcome.
Showing 6 sources
- 01
Evening Primrose Oil: Usefulness and Safety ↗
Official evidence and safety overview
Current page or report reviewed; scope and limits retained.
Detail: Evidence limits, eczema synthesis and safety cautions.
- 02
A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment. ↗
Systematic review and meta-analysis
Current page or report reviewed; scope and limits retained.
Detail: 13 trials and 1,752 randomized participants; no clear comparative pain advantage.
- 03
Effectiveness of Evening Primrose and Vitamin E for Cyclical Mastalgia: A Prospective Study. ↗
Randomized combination trial
Current page or report reviewed; scope and limits retained.
Detail: 126 women; EPO 1,000 mg twice daily, vitamin E 400 mg daily, combination or placebo for six months.
- 04
Effects of evening primrose oil on treating painful diabetic neuropathy: a randomized, double-blind, clinical trial. ↗
Small randomized clinical trial
Current page or report reviewed; scope and limits retained.
Detail: Daily versus every-12-hour 1,000 mg administrations over four weeks; small mixed-placebo design.
- 05
Questions and Answers on Dietary Supplements ↗
U.S. regulatory overview
Current page or report reviewed; scope and limits retained.
Detail: Supplements generally lack efficacy preapproval.
- 06
Product Licensing ↗
Canadian licensing overview
Current page or report reviewed; scope and limits retained.
Detail: Finished natural health products require licensing and authorized labels.
No matching sources
Try a different term or show the full list.